SU421202A3 - Способ получения комплексных полинуклеотидов - Google Patents
Способ получения комплексных полинуклеотидовInfo
- Publication number
- SU421202A3 SU421202A3 SU1657112A SU1657112A SU421202A3 SU 421202 A3 SU421202 A3 SU 421202A3 SU 1657112 A SU1657112 A SU 1657112A SU 1657112 A SU1657112 A SU 1657112A SU 421202 A3 SU421202 A3 SU 421202A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- compound
- complex
- solution
- poly
- hsp
- Prior art date
Links
- 102000040430 polynucleotide Human genes 0.000 title description 6
- 108091033319 polynucleotide Proteins 0.000 title description 6
- 239000002157 polynucleotide Substances 0.000 title description 6
- 238000000034 method Methods 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 description 21
- 239000000243 solution Substances 0.000 description 14
- 230000005855 radiation Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 102000006382 Ribonucleases Human genes 0.000 description 4
- 108010083644 Ribonucleases Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010035737 Pneumonia viral Diseases 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 208000009421 viral pneumonia Diseases 0.000 description 3
- -1 Compound Compound Chemical class 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000543404 Cytidia Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 231100000171 higher toxicity Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 229940028843 inosinic acid Drugs 0.000 description 1
- 239000004245 inosinic acid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3789670A | 1970-05-15 | 1970-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU421202A3 true SU421202A3 (ru) | 1974-03-25 |
Family
ID=21896942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1657112A SU421202A3 (ru) | 1970-05-15 | 1971-05-10 | Способ получения комплексных полинуклеотидов |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3666646A (Direct) |
| AR (1) | AR199872A1 (Direct) |
| BE (1) | BE767190A (Direct) |
| CA (1) | CA985677A (Direct) |
| DE (1) | DE2124123A1 (Direct) |
| ES (1) | ES391016A1 (Direct) |
| FR (1) | FR2100660B1 (Direct) |
| GB (1) | GB1355516A (Direct) |
| HU (1) | HU164639B (Direct) |
| IE (1) | IE35215B1 (Direct) |
| IL (1) | IL36772A0 (Direct) |
| NL (1) | NL7105076A (Direct) |
| NO (1) | NO131754B (Direct) |
| SU (1) | SU421202A3 (Direct) |
| ZA (1) | ZA712259B (Direct) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0113162B1 (en) * | 1982-09-16 | 1989-07-19 | Hem Research, Inc. | Anti-proliferative action of dsnras on tumor cells |
| KR100455814B1 (ko) | 1999-02-15 | 2004-11-06 | 니뽄 신야쿠 가부시키가이샤 | 단쇄화 폴리뉴클레오티드 및 그 제법 |
| CA2587676A1 (en) * | 2004-11-19 | 2006-05-26 | Institut Gustave Roussy | Improved treatment of cancer by double-stranded rna |
| WO2006131023A1 (en) * | 2005-06-08 | 2006-12-14 | Newbiomed Pika Pte Ltd | Polyinosinic acid-polycytidylic acid-based adjuvant |
| US20070166800A1 (en) * | 2006-01-13 | 2007-07-19 | Haixiang Lin | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant |
| US20070166239A1 (en) * | 2006-01-13 | 2007-07-19 | Haixiang Lin | Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| EP2116602A1 (en) | 2008-05-07 | 2009-11-11 | Institut Gustave Roussy | Combination products for treating cancer |
| EA201290876A1 (ru) | 2010-03-05 | 2013-03-29 | Президент Энд Феллоуз Оф Гарвард Колледж | Композиции индуцированных дендритных клеток и их использование |
| CN106163554B (zh) | 2014-12-23 | 2021-09-07 | 依生生物制药(新加坡)私人有限公司 | 一种包含pika佐剂的狂犬病组合物 |
| US20240216364A1 (en) | 2021-04-28 | 2024-07-04 | Enyo Pharma | Strong potentiation of tlr3 agonists effects using fxr agonists as a combined treatment |
-
1970
- 1970-05-15 US US37896A patent/US3666646A/en not_active Expired - Lifetime
-
1971
- 1971-04-08 ZA ZA712259A patent/ZA712259B/xx unknown
- 1971-04-15 NL NL7105076A patent/NL7105076A/xx not_active Application Discontinuation
- 1971-05-04 IL IL36772A patent/IL36772A0/xx unknown
- 1971-05-05 CA CA112,273A patent/CA985677A/en not_active Expired
- 1971-05-10 GB GB1405071*[A patent/GB1355516A/en not_active Expired
- 1971-05-10 SU SU1657112A patent/SU421202A3/ru active
- 1971-05-10 ES ES391016A patent/ES391016A1/es not_active Expired
- 1971-05-11 IE IE592/71A patent/IE35215B1/xx unknown
- 1971-05-12 FR FR7117104A patent/FR2100660B1/fr not_active Expired
- 1971-05-13 AR AR235517A patent/AR199872A1/es active
- 1971-05-14 NO NO1838/71A patent/NO131754B/no unknown
- 1971-05-14 DE DE19712124123 patent/DE2124123A1/de not_active Withdrawn
- 1971-05-14 BE BE767190A patent/BE767190A/xx unknown
- 1971-05-14 HU HUME1359A patent/HU164639B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2124123A1 (de) | 1971-12-02 |
| ES391016A1 (es) | 1974-04-01 |
| FR2100660B1 (Direct) | 1975-06-06 |
| US3666646A (en) | 1972-05-30 |
| ZA712259B (en) | 1972-11-29 |
| AR199872A1 (es) | 1974-10-08 |
| HU164639B (Direct) | 1974-03-28 |
| CA985677A (en) | 1976-03-16 |
| IL36772A0 (en) | 1971-07-28 |
| IE35215B1 (en) | 1975-12-10 |
| BE767190A (fr) | 1971-11-16 |
| IE35215L (en) | 1971-11-15 |
| NO131754B (Direct) | 1975-04-14 |
| NL7105076A (Direct) | 1971-11-17 |
| GB1355516A (en) | 1974-06-05 |
| FR2100660A1 (Direct) | 1972-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU421202A3 (ru) | Способ получения комплексных полинуклеотидов | |
| Yoshida et al. | Sulfation of the immunomodulating polysaccharide lentinan: a novel strategy for antivirals to human immunodeficiency virus (HIV) | |
| Vongchan et al. | Anticoagulant activity of a sulfated chitosan | |
| Creighton et al. | Antitumour activity in a series of bis diketopiperazines | |
| Ősz et al. | Efficient inhibition of muscle and liver glycogen phosphorylases by a new glucopyranosylidene-spiro-thiohydantoin | |
| Ricevuti et al. | Role of granulocytes in endothelial injury in coronary heart disease in humans | |
| US6004953A (en) | Agent for suppressing tumor growth | |
| JPH0454124A (ja) | 抗ウィルス剤 | |
| US6255291B1 (en) | Composition and method for treating cancer and immunological disorders resulting in chronic conditions | |
| Smith et al. | Formation of S-adenosylethionine by ethionine-treated rats | |
| EP3398971A1 (en) | Sulfated heparin oligosaccharide and preparation method and application thereof | |
| Hassan et al. | A close look at neutropenia among cancer patients—Risk factor and management | |
| US2387275A (en) | Polymerization of sugars | |
| JPS6115840A (ja) | 免疫賦活剤 | |
| SU1405691A3 (ru) | Способ получени человеческого гамма-интерферона | |
| Kassel et al. | Interferon-mediated oncolysis in spontaneous murine leukemia | |
| US4223109A (en) | Calcium salts of divinyl ether--maleic anhydride copolymer | |
| JP3459268B2 (ja) | 抗癌剤 | |
| RU2499002C1 (ru) | Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе | |
| Jones et al. | A simple method for the preparation of ‘ribonucleoside dialdehydes’ and some comments on their structure | |
| JP5098015B2 (ja) | 菌体膜傷害性・抗菌性物質とその利用方法 | |
| CN101679469A (zh) | 改性的寡－β－(1,3)－葡聚糖用于治疗免疫系统疾病的用途、寡－β－(1,3)－葡聚糖－(1,3)－甘露糖、寡－β－(1,3)－葡聚糖－(1,3)－甘露醇和它们的衍生物、它们的制备方法以及含有它们的药物 | |
| Babkin | Theoretical and practical development of new drugs for medicine based on larch biomass extracts | |
| RU2185172C2 (ru) | Способ коррекции показателей крови и увеличения продолжительности жизни больных т-лимфолейкозом животных | |
| RU2121839C1 (ru) | Средство, обладающее противоопухолевой и анальгетической активностью |